Hair thinning
Conditions
Interventions
Placebo TMD1 hair growth product applied to the scalp twice daily for 24 weeks
Apply a middle concentration of TMD1 hair growth product to the scalp twice daily for 24 weeks
Apply a high concentration
Sponsors
TMC Medical Corporation,Tokyo Memorial Clinic
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Asian women between the ages of 45 and 65 2. Subjects with thinning hair equivalent to Ludwig Scale I-2 to II-2 3. Subjects who have been informed of the purpose and content of the study prior to the study, have the capacity to make decisions, and have given their written consent.
Exclusion criteria
Exclusion criteria: 1. Those who have undergone hair transplantation 2. Persons who have dyed, bleached or permanent hair within 3 months of the screening test. 3. Persons who may show allergic symptoms to test substance components. 4. Persons who may show skin allergy symptoms or skin hypersensitivity. 5. Persons with a history of serious heart disease, renal disease, liver disease, cancer, or thyroid dysfunction in the past. 6. Persons who have not used health foods, cosmetics, quasi-drugs, or medicines that may affect the test results for more than 6 months. 7. Women who are pregnant or possibly pregnant and women who are breast-feeding 8. Other persons whom the principal investigator deems inappropriate to be included in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage change in number of hairs after 24 weeks of use | — |
Countries
Japan
Contacts
Public ContactHiromu Katsuta
Re-Life.inc Clinical Development Division
Outcome results
None listed